Predicting the Role of DNA Polymerase β Alone or with KRAS Mutations in Advanced NSCLC Patients Receiving Platinum-Based Chemotherapy

Clinical data suggest that only a subgroup of non-small cell lung cancer (NSCLC) patients has long-term benefits after front-line platinum-based therapy. We prospectively investigate whether KRAS status and DNA polymerase β expression could help identify patients responding to platinum compounds. Pr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Med
Main Authors: Alvisi, Maria Francesca, Ganzinelli, Monica, Linardou, Helena, Caiola, Elisa, Lo Russo, Giuseppe, Cecere, Fabiana Letizia, Bettini, Anna Cecilia, Psyrri, Amanda, Milella, Michele, Rulli, Eliana, Fabbri, Alessandra, De Maglie, Marcella, Romanelli, Pierpaolo, Murray, Samuel, Ndembe, Gloriana, Broggini, Massimo, Garassino, Marina Chiara, Marabese, Mirko
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465625/
https://ncbi.nlm.nih.gov/pubmed/32751518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082438
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares